Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News OraSure Technologies Inc OSUR

Healthcare Medical Instruments & Supplies
OraSure Technologies, Inc. provides point-of-care and home diagnostic tests, sample management solutions, and microbiome laboratory and analytical services. The Company's product portfolio is divided into diagnostics products and sample management solutions. Its business consists of the development, manufacture, marketing and sale of diagnostic products and specimen collection devices using its... see more

Recent & Breaking News (NDAQ:OSUR)

OraSure Reports 4Q22 Record Revenue of $123.1 Million Growing 94% Year-Over-Year; Positions for Longer-Term Growth and Profitability

GlobeNewswire February 14, 2023

2022 Fourth Quarter Earnings Conference Call Tuesday, February 14, 2023, 5:00 p.m. ET

GlobeNewswire February 7, 2023

OraSure Technologies Continues its Dedication to Ending the HIV Epidemic

GlobeNewswire December 1, 2022

OraSure Technologies to Present at Stephens Annual Investment Conference

GlobeNewswire November 14, 2022

OraSure Reports 3Q22 Record Revenue of $116.5 Million Growing 116% Year-Over-Year

GlobeNewswire November 8, 2022

OraSure Technologies Receives General Clearance for its ORAcollect®•Dx Device for Over-the Counter (OTC) Use from the U.S. Food and Drug Administration (FDA)

GlobeNewswire November 3, 2022

InteliSwab® COVID-19 Rapid Test Now Available in Amazon's Online Store

GlobeNewswire November 2, 2022

2022 Third Quarter Earnings Conference Call Tuesday, November 8, 2022, 5:00 p.m. ET

GlobeNewswire November 1, 2022

OraSure Technologies Receives $8.6 Million BARDA Contract to Develop 2nd Generation Ebola Test

GlobeNewswire September 28, 2022

OraSure Wins Contract to Supply "Together Take Me Home," HIV Self-Testing Initiative Sponsored by the Centers for Disease Control and Prevention

GlobeNewswire September 20, 2022

OraSure Partners with Mars Petcare in One of the Largest Ever Microbiome Studies to Evaluate Pet Health

GlobeNewswire September 14, 2022

OraSure Reports 2Q22 Record Revenue of $80.2 Million Growing 39% Year-Over-Year

GlobeNewswire August 9, 2022

OraSure Technologies to Hold 2022 Second Quarter Earnings Conference Call Tuesday, August 9, 2022, 5:00 p.m. ET

GlobeNewswire August 2, 2022

OraSure's Ongoing Commitment to End the Hepatitis C Epidemic Heats Up at the Racetrack

GlobeNewswire July 28, 2022

OraSure Technologies Launches New Product for Microbiome Researchers to Study DNA and RNA

GlobeNewswire July 14, 2022

OraSure Technologies Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire June 8, 2022

InteliSwab® COVID-19 Rapid Test Selected by Federal Government for Nationwide School Testing

GlobeNewswire May 25, 2022

Carrie Eglinton Manner Appointed Chief Executive Officer of OraSure

GlobeNewswire May 23, 2022

InteliSwab® COVID-19 Rapid Test Validated to Detect the Omicron BA.2, BA.2.12.1, BA.3 and BA.5 Subvariants

GlobeNewswire May 17, 2022

OraSure Reports 1Q22 Record Revenue of $67.7 Million; +16% Year-Over-Year With 21% Growth in Non-COVID Revenue

GlobeNewswire May 10, 2022